Beck Mack & Oliver LLC Amarin Corp Plcuk Transaction History
Beck Mack & Oliver LLC
- $4.7 Billion
- Q4 2024
A detailed history of Beck Mack & Oliver LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Beck Mack & Oliver LLC holds 22,000 shares of AMRN stock, worth $13,420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,000
Previous 30,000
26.67%
Holding current value
$13,420
Previous $18,000
44.44%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AMRN
# of Institutions
177Shares Held
69.9MCall Options Held
258KPut Options Held
98K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$15.2 Million3.89% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$7.57 Million0.38% of portfolio
-
Morgan Stanley New York, NY2.55MShares$1.55 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.53 Million1.0% of portfolio
-
Waterfront Wealth Inc.2.48MShares$1.51 Million0.31% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $246M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...